Coherus Biosciences
Redwood City
About Coherus Biosciences
Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for the treatment of oncology and inflammatory diseases. It focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $1.3B
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: nasdaq:CHRS
- Website: coherus.com
- Phone: (650) 649-3530
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/coherus-biosciences-14307 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.